CD4 and colorectal carcinoma: Calnexin or CANX is an ER stress chaperone transmembrane protein involved in glycoprotein folding, is considered a prognostic indicator and therapeutic target in CRC [25], and is found to restrict antitumor CD4+ and CD8+ T cells [26] in oral cancer.